Korea United Pharm Beheer
Beheer criteriumcontroles 0/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Duk-Young Kang
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | no data |
| Eigendom CEO | 29.0% |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
CEO
Duk-Young Kang (77 yo)
no data
Tenure
Mr. Deok-Yeong Kang serves as the Chief Executive Officer of Korea United Pharm Inc. Mr. Kang served as the Chief Executive Officer of Yeonhap Medical. He served as a Director of Korea United Pharm Inc. Mr...